Wednesday, August 19, 2015 4:32:56 PM
When it comes to OTC and pinks, you won't be hearing of retaliatory actions taken by disgruntled groups of dissatisfied share holders. The main reason for this lies in the fact that there is simply not enough money involved for legal people to come out whole and enriched. As an example, today there was not a single share traded in FDMF. That speaks to there being absolutely no demand for this company's shares.
Also, I might add that I sold off when BK was (in my mind) going berserk. Shortly thereafter he advised everyone to load up on millions of shares. I found that ludicrously naïve on the parts of some on this board. I'd never seen such flagrant disregard for investors.
He was so bold, I think that accounts for the disbelief generated by formerly loyal followers. And I can well understand it, frankly, for he went so far beyond anything I'd seen over the years.
A voice in my brain is recognizing that everyone here was foolishly naïve. But it doesn't stop there for my experiences are much more extensive than that of many others (but not all, of course)yet I, too, got suckered in.
BK is good at this. He knows how to play people for suckers and he apparently delights in doing it. In my mind he is as low as they get. On the other hand, the reason we got duped is because we don't have bad bones in ourselves like he does in his. I'm glad. And this is why we couldn't anticipate his moves or lack thereof.
These are my opinions only, and I'm appreciative of the opportunity to speak out here.
Recent FHLD News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/20/2024 08:13:26 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/14/2024 10:29:03 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/24/2024 04:30:48 PM
- FREEDOM HOLDINGS (FHLD) SHAREHOLDER UPDATE; Freedom, Holdings Inc symbol: FHLD 15C-211 nears final approval from FINRA • InvestorsHub NewsWire • 12/08/2023 11:10:09 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM